跳至主要内容
临床试验/NL-OMON55564
NL-OMON55564招募中不适用

Toxicity prediction in radiotherapy for pelvic cancers, assessing the added value of biological parameters to RT treatment planning variables - StopRTox

Academisch Medisch Centrum0 个研究点目标入组 200 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
招募中
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • -Histologically confirmed urogenital carcinoma (i.e. cervix, uterus, vagina,
  • vulva, prostate, bladder) or rectal cancer
  • -Newly diagnosed patients who are to receive 'radical' EBRT or already treated
  • patients, 6 to 24 months after curative EBRT. (Both patients receiving primary
  • RT and those receiving adjuvant (post-operative) RT are eligible for this study)
  • -Proficient in Dutch
  • -Written informed consent prior to participation

排除标准

  • -Radiotherapy for recurrent disease
  • -Patients with prostate cancer who had prostatectomy or iodine-125
  • brachytherapy
  • -Psychosocial or somatic disorders in the medical history, limiting the
  • possibilities for adequate follow-up

研究者

相似试验

Toxicity prediction in radiotherapy for pelvic... | 临床试验